Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6576665 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Apr, 2021
(3 years ago) |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 02 April, 2001
Treatment: NA
Dosage: CAPSULE
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6576665 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Apr, 2021
(3 years ago) | |
US6875445 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Jul, 2021
(3 years ago) |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 02 April, 2001
Treatment: NA
Dosage: CAPSULE
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8592480 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Jul, 2027
(2 years from now) | |
US9089528 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Jul, 2027
(2 years from now) | |
US8591938 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Feb, 2030
(5 years from now) |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 18 April, 2011
Treatment: Use of phoslyra for reduction of serum phosphorous in patients
Dosage: SOLUTION